Skip to main content
SpringerLink
Log in

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

  • Editorial
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

In vivo nuclear magnetic resonance spectroscopy (MRS) of the human brain is a recently developed technique which allows to assay noninvasively in vivo key molecules of brain metabolism. After a review of the origin of the signals detected by phosphorus and proton MRS of human brain, the impact of MRS on clinical neurology is examined. MRS of the brain does not purport to be a metabolic “biopsy”, but unique applications for brain MRS are (1) quantitating the oxidative state of the brain and defining neuronal death, (2) assessing and mapping neuron damage, (3) evaluating membrane alterations, and (4) characterizing encephalopathies. In the near future brain MRS will be performed routinely after conventional MRI, as a valuable metabolic (and functional) complement to the anatomical evaluation of cerebral pathologies, particularly the toxic, metabolic and infectious encephalopathies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adalsteinsonn E, Spielman DM, Wright GA, Pansy JM, Meyer CH, Macovski A (1993) Incorporating lactate/lipid discrimination into a spectroscopic imaging sequence. Magn Reson Med 30:124–130

    PubMed  Google Scholar 

  2. Agranoff BW (1989) Lipids. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 91–107

    Google Scholar 

  3. Aichner F, Felber S, Birbamer G, Luz G, Judmaier W, Schutzhard E (1992) Magnetic resonance: a non invasive approach to metabolism, circulation and morphology in human brain death. Ann Neurol 32:507–511

    Article  PubMed  Google Scholar 

  4. Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42:733–738

    PubMed  Google Scholar 

  5. Alger JR, Symko SC, Bizzi A, Posse S, DesPres D, Armstrong MR (1993) Absolute quantitation of short TE brain 1-H MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 17:191–199

    PubMed  Google Scholar 

  6. Arnold DL, Shoubridge EA, Villemure J-G, Feindel W (1990) Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumor grading. NMR Biomed 3:184–189

    PubMed  Google Scholar 

  7. Arnold DL, Emrich JF, Shoubridge EA, Villemure J-G, Feindel W (1991) Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg 74:447–453

    PubMed  Google Scholar 

  8. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP (1992) Proton Magnetic Resonance spectroscopic imaging for metabolites characterization of demyelinating plaques. Ann Neurol 31:235–241

    Article  PubMed  Google Scholar 

  9. Asrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia; the ischemic penumbra. Stroke 6:723–725

    Google Scholar 

  10. Austin SJ, Connelly A, Gadian DG, Benton JS, Brett EM (1991) Localized H-1 NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 19:439–445

    PubMed  Google Scholar 

  11. Azzopardi D, Wyatt JS, Cady EB, Delpy DT, Baudin J, Stewart AL, Hope PL, Hamilton PA, Reynolds EOR (1989) Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 25:445–451

    PubMed  Google Scholar 

  12. Bachelard H, Badar-Gofer R (1993) NMR spectroscopy in Neurochemistry. J Neurochem 61:412–429

    PubMed  Google Scholar 

  13. Bain PG, O'Brien MD, Keevil SF, Porter DA (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31:147–154

    Article  PubMed  Google Scholar 

  14. Barbiroli B, Mantagna P, Cortelli P, Funicello R, Iotii S, Monari L, Pierangeli G, Zaniol P, Lugaresi E (1992) Abnormal brain and muscle energy metabolism shown by P-31 magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42:1209–1214

    PubMed  Google Scholar 

  15. Barker PB, Bryan RN, Kumar AJ, Naidu S (1992) Proton NMR spectroscopy of Canavan's disease. Neuropediatrics 23:263–267

    PubMed  Google Scholar 

  16. Beal MF, Human BT, Korshetz W (1993) Do defect in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125–131

    Article  PubMed  Google Scholar 

  17. Behar KL, Ogino T (1993) Characterization of macromolecules resonances in the 1-H NMR spectrum of rat brain. Magn Reson Med 30:38–44

    PubMed  Google Scholar 

  18. Beckmann N, Turkalj I, Seelig J, Keller U (1991) 13-C NMR for the assessment of human brain glucose metabolism in vivo. Biochemistry 30:6362–6366

    Article  PubMed  Google Scholar 

  19. Berkelbach van der Sprenkel JW, Knufman NMJ, Van Rijen PC, Luyten PR, Den Holander JA, Tulleken CAF (1992) Proton spectroscopic imaging in cerebral ischaemia. Where we stand, and what can be expected. Adv Tech Stand Neurosurg 19:3–17

    PubMed  Google Scholar 

  20. Birken DL, Oldendorf WH (1989) N-Acetyl-aspartic acid: a literature review of a compound prominent in H1-NMR spectroscopic studies of the brain. Neurosci Behav Rev 13:23–31

    Google Scholar 

  21. Blakely RD (1988) The Neurobiology of N-acetylaspartylglutamate. Int Rev Neurobiol 30:39–100

    PubMed  Google Scholar 

  22. Blass JP, Shen RKF, Cerdabaum JM (1988) Energy metabolism in disorders of the nervous system. Rev Neurol (Paris) 144:543–563

    Google Scholar 

  23. Boesch C, Gruetter R, Martin E, Duc G, Wütrich K (1989) Variations in the in vivo P-31 MR spectra of the developing brain during post-natal life. Radiology 172:197–199

    PubMed  Google Scholar 

  24. Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348

    PubMed  Google Scholar 

  25. Bottomley PA (1989) Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 170:1–15

    PubMed  Google Scholar 

  26. Bottomley PA, Hardy CJ (1989) Rapid, reliable, in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem 35:392–395

    PubMed  Google Scholar 

  27. Bottomley PA, Hardy CJ, Cousins JP, Amstrong M, Wagle WA (1990) AIDS dementia complex: brain energy phosphate metabolic deficit. Radiology 176:407–411

    PubMed  Google Scholar 

  28. Bottomley PA, Cousins JP, Hardy DJ, Pendrey DL, Wagle WA, Hardy CJ, Eames FA, McCafrey RJ, Thomson DA (1992) Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology 183:695–699

    PubMed  Google Scholar 

  29. Brenner RE, Munro PMG, Williams SCR, Bell JD, Barker GJ, Hawkins CP, Landon DN, Donald WI (1993) The proton NMR spectrum in acute EAE: the significance of the change in Cho: Cr ratio. Magn Reson Med 29:737–745

    PubMed  Google Scholar 

  30. Brenton DP, Garrod PJ, Krywawhych S, Reynolds EOR, Bachelard HS, Cox DW, Morris PG (1985) Phosphoethanolamine is a major constituent of phosphomonoester peak detected by P-31 NMR in newborn brain. Lancet I, 115

    Article  Google Scholar 

  31. Brown GG, Levine SR, Petegreew JW, Gdowski JW, Bueri JA, Helpern JA, Welch KMA (1989) In vivo 31-P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39:1423–1427

    PubMed  Google Scholar 

  32. Brown TR, Kincaid BM, Ugurbil K (1982) NMR chemical shift Imaging in three demensions. Proc Natl Acad Sci USA 79:3523–3526

    PubMed  Google Scholar 

  33. Browning JL (1981) NMR studies of the structural and motionnal properties of phospholipids in membranes. In: Knight R (ed) Liposomes: from physical structure to therapeutic applications. Elsevier North Holland, Amsterdam, pp 189–242

    Google Scholar 

  34. Bruhn H, Frahm J, Gyngell M, Merbold KD, Hanïcke W, Sauter R (1989) Cerebral metabolism in man after acute stroke: new observation using localized proton NMR spectroscopy. Magn Reson Med 9:126–131

    PubMed  Google Scholar 

  35. Bruhn H, Frahm J, Gyngell M, Merbold KD, Hanïcke W, Sauter R, Hamburger C (1989) Non invasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo. Initial experience in patients with cerebral tumors. Radiology 172:541–548

    PubMed  Google Scholar 

  36. Bruhn H, Kruse B, Korenke GC, Manefeld F, Hänïcke W, Merboldt KD, Frahm J (1992) Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 16:335–344

    PubMed  Google Scholar 

  37. Bruhn H, Michaelis T, Merbold KD, Hanïcke W, Gyngell M, Hamburger C, Frahm J (1992) On the interpretation of proton NMR spectra from brain tumors in vivo and in vitro. NMR Biomed 5:253–258

    PubMed  Google Scholar 

  38. Bruhn H, Frahm J, Merbold KD, Hanïcke W, Hanefeld F, Christen HJ, Kruse B, Bauer HJ (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 32:140–150

    Article  PubMed  Google Scholar 

  39. Carter CJ, Benavidés J, Dubois A (1989) The biochemistry of Huntington's disease chorea. In: Quinn NP, Jenner PG (eds) Disorders of movement: clinical, pharmacological and physiological aspects, vol 34. Academic Press, London, pp 468–494

    Google Scholar 

  40. Cervos-Navarro J, Diemer NH (1991) Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 6:149–182

    PubMed  Google Scholar 

  41. Chance B (1989) What are the goals of magnetic resonance research. NMR Biomed 2:179–187

    Google Scholar 

  42. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:633–634

    Article  Google Scholar 

  43. Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IVD, Newman SP, Harrisson MJ (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188:119–124

    PubMed  Google Scholar 

  44. Clarke DD, Lajtha AL, Maker HS (1989) Intermediary metabolism. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 541–564

    Google Scholar 

  45. Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA (1991) H-1 NMR characterization of normal cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B 12 deficient patient, NMR Biomed 4:192–200

    PubMed  Google Scholar 

  46. Confort-Gouny S, Vion-Dury J, Cozzone PJ (1992) Méthodes de localisation du signal de RMN in vivo. Vers une approche métabolique des pathologies. J Radiol (Paris) 73:13–21

    Google Scholar 

  47. Confort-Gouny S, Chabrol B, Vion-Dury J, Mancini J, Cozzone PJ (1993) MRI and localized proton MRS in an early infantile form of neuronal ceroid-lipofuscinosis. Pediatr Neurol 9:57–60

    Article  PubMed  Google Scholar 

  48. Confort-Gouny S, Vion-Dury J, Ncoli F, Dano P, Donnet A, Grazziani N, Gastaut JL, Grisoli F, Cozzone PJ (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic definition of neurological diseases. J Neurol Sci 118:123–133

    Article  PubMed  Google Scholar 

  49. Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ (1993) Localized proton MR spectroscopy in X-linked adrenoleukodystrophy. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1565

  50. Connely A, Cross JH, Gadian DG, Hunter JV, Kirkham FJ Leonard JV (1993) Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 33:77–81

    PubMed  Google Scholar 

  51. Corbett RJT, Laptook AR, Garcia D, Ruley JI (1992) Cerebral acid buffering capacity at different ages measured in vivo by P-31 and H1 nuclear magnetic resonance spectroscopy. J Neurochem 59:216–226

    PubMed  Google Scholar 

  52. Christiansen P, Jenriksen O, Subgaard M, Gideon P, Larsson HBW (1993) In vivo quantification of brain metabolites by 1H-MRS using water as and internal standard. Magn Reson Imaging 11:107–118

    Article  PubMed  Google Scholar 

  53. Dager SR, Marro KI, Richards TL, Matzger GD (1992) Localized magnetic resonance spectroscopy measurement of brain lactate infusion in healthy volunteers. Life Sci 51:973–985

    Article  PubMed  Google Scholar 

  54. Degani H, Alger JR, Shulman RG, Petroff OAC, Prichard JW (1987) 31P Magnetization transfer studies of creatine kinase kinetics in living rabbit brain. Magn Reson Med 5:1–12

    PubMed  Google Scholar 

  55. Deicken RE, Hubesch B, Jensen PC, Sappey-Marinier D, Krell P, Wisniewski A, Vanderburg D, Parks R, Fein G, Weiner MW (1991) Alteration in brain phosphate metabolic concentrations in patients with human immunodeficiency virus infection. Arch Neurol 48:203–209

    PubMed  Google Scholar 

  56. Delivoria-Papadopoulos M, DiGiacomo JE (1990) 31-P nuclear magnetic resonance spectroscopy in the human neonatal brain. Semin Perinatol 14:248–257

    PubMed  Google Scholar 

  57. Demaerel P, Johannik K, Van Hecke PV, Van Ongeval C, Verellen S, Marchal G, Wilms G, Plets C, Goffn J, Van Callenbergh F, Lammens M, Baert AL (1991) Localized H-1 NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15:67–76

    PubMed  Google Scholar 

  58. Detre JA, Wang Z, Bogdan AR, Gusnar DA, Bay CA, Bingham PM, Zimmerman RA (1991) Regional variations in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy. Ann Neurol 29:218–221

    Article  PubMed  Google Scholar 

  59. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW (1992) Human brain infarction: proton MR spectroscopy. Radiology 183:711–718

    PubMed  Google Scholar 

  60. Duijn JH, Matson GB, Maudsley AA, Weiner MW (1992) 3D-Phase encoding 1H spectroscopic imaging on human brain. Magn Reson Imaging 10:315–319

    Article  PubMed  Google Scholar 

  61. Duijn JH, Gillen J, Sobering G, Zijl PCM van, Moonen CTW (1993) Multisection proton imaging of the brain. Radiology 188:277–282

    PubMed  Google Scholar 

  62. Eleff SM, Barker PB, Blackband J, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O (1990) Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrate: low levels of brain phosphocreatine. Ann Neurol 27:626–630

    Article  PubMed  Google Scholar 

  63. Faden AI, Salzman S (1992) Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29–35

    Article  PubMed  Google Scholar 

  64. Farooqui AA, Horroks LA (1991) Excitatory amino-acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res Rev 16:171–191

    Article  PubMed  Google Scholar 

  65. Felber SR, Aichner FT, Sauter R, Gerstenbrand F (1992) Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Stroke 23:1106–1110

    PubMed  Google Scholar 

  66. Felber SR, Sperl W, Chemelli A, Murr C, Wendel U (1993) Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol 33:396–401

    Article  PubMed  Google Scholar 

  67. Fishman RA (1989) Brain edema and disorders of intracranial pressure. In: Rowland LP (ed) Merritt's textbook of neurology. Lea and Febinger, Philadelphia, pp 262–271

    Google Scholar 

  68. Flynn CJ, Farooqui AA, Horroks LA (1989) Ischaemia and hypoxia. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 783–795

    Google Scholar 

  69. Ford CC, Griffey RH, Matwiyoff NA, Rosenberg GA (1992) Multivoxel H1-MRS of stroke. Neurology 42:1408–1412

    PubMed  Google Scholar 

  70. Frahm J, Michaelis T, Merboldt K-D, Hänicke W, Gyngell ML, Chien D, Bruhn H (1989) Localized NMR spectroscopy in vivo progress and problems. NMR Biomed 2:188–195

    PubMed  Google Scholar 

  71. Frahm J, Bruhn H, Hänïcke W, Merboldt K-D, Mursch K, Markakis E (1991) Localized proton NMR spectroscopy of brain tumors using short echo time STEAM sequences. J Comput Assist Tomogr 15:915–922

    PubMed  Google Scholar 

  72. Frahm J, Michaelis T, Merboldt K-D, Hänïcke W, Gyngell ML, Bruhn H (1991) On the N-acetyl-methyl-resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed 4:201–211

    PubMed  Google Scholar 

  73. Federico A, Dotti MT, Meloni M, Gagelli E, Vivi A, Valensin G (1988) H-1 NMR analysis of CSF in normal subjects and in a case of mitochondrial encephal-neuro-myopathy. Magn Res Med Biol 1:305–313

    Google Scholar 

  74. Fulham M, Bizi A, Dietz MJ, Shih HHL, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675–686

    PubMed  Google Scholar 

  75. Gadian DG, Shaw D, Moonen CTW, Zijl P van (1993) Advances in proton magnetic resonance spectroscopy of the brain. A report of a workshop held in Oxford. Magn Reson Med 30:1–3

    PubMed  Google Scholar 

  76. Gadian DG, Williams SR, Bates TE, Kaupine RA (1993) Brain damage studied by NMR and other methods: NMR spectroscopy, current status and future possibilities. Acta Neurochir (Wien) [Suppl] 57:1–8

    Google Scholar 

  77. Gibson GE, Pulsinelli W, Blass J, Duffy TE (1981) Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247–1254

    Article  PubMed  Google Scholar 

  78. Gideon P, Henriksen O, Sperling B, Christiansen P, Skyhoj Olsen T, Jorgensen HS, Arlien-Soborg P (1992) Early time course of N-acetyl-aspartate, creatine and phosphocreatine and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 23:1566–1572

    PubMed  Google Scholar 

  79. Goplerud JM, Delivoria-Papadopoulos M (1993) Nuclear magnetic resonance imaging and spectroscopy following asphyxia. Clin Perinatol 20:345–367

    PubMed  Google Scholar 

  80. Graham GG, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OAC, Schulman RG, Pritchard JW (1992) Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23:333–340

    PubMed  Google Scholar 

  81. Griffey RH, Brown MS, Bankhurst AD, Sibbit RR, Sibbit WL (1990) Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear resonance spectroscopy. Arthritis Rheum 33:827–833

    PubMed  Google Scholar 

  82. Grodd W, Krageloh-Mann I, Klose U, Sauter R (1991) Metabolic and destructive brain disorders in children: findings with localized proton localized MR spectroscopy. Radiology 481:173–181

    Google Scholar 

  83. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA (1992) MR proton spectroscopy in multiple sclerosis. Am J Neuroradiol 13:1535–1543

    PubMed  Google Scholar 

  84. Grutter R, Rothman DL, Novotny EJ, Shulman GI, Pricard JW, Shulman RG (1992) Detection and assignment of the glucose signal in H1 NMR difference spectra of the human brain. Magn Reson Med 27:183–188

    PubMed  Google Scholar 

  85. Gupta RK, Moore RD (1980)31P NMR studies of intracellular free Mg2+ in intact frog squelettal muscle. J Biol Chem 255:387–399

    Google Scholar 

  86. Gupta RK, Saraswat VA, Poptani H, Dhilman RK, Kohli A, Gujral RB, Naik SR (1993) Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol 88:670–674

    PubMed  Google Scholar 

  87. Hacke W, Hennerici M, Gelmers HJ, Kramer G (1991) Cerebral ischaemia. Springer, Berlin Heidelberg New York

    Google Scholar 

  88. Halvorson HR, Vande Linde AMQ, Helpern JA, Welch KM (1992) Assessment of magnesium concentrations by 31-P NMR in vivo. NMR Biomed 5:53–58

    PubMed  Google Scholar 

  89. Hanstock CC, Rothman DL, Prichard JW, Jue T, Shulman RG (1988) Spatially localized 1H-NMR spectra of metabolites in the human brain. Proc Natl Acad Sci USA 185:1821–1825

    Google Scholar 

  90. Heindel W, Kugel H, Toth B (1993) Non invasive detection of increased glycine content by proton NMR spectroscopy in the brains of two infants with non ketotic hyperglycinemia. Am J Neuroradiol 14:629–635

    PubMed  Google Scholar 

  91. Hennig J, Pfister H, Ernst T, Ott D (1992) Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 5:193–199

    PubMed  Google Scholar 

  92. Herholz K, Heindel W, Luyten PR, Den Hollender JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD (1992) In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 31:319–327

    Article  PubMed  Google Scholar 

  93. Herschap A (1992) Current status of human in vivo NMR spectroscopy. Eur J Radiol 14:117–123

    Article  PubMed  Google Scholar 

  94. Herz L (1989) Is Alzheimer's disease and anterograde degeneration, originating in the brain stem, and disrupting metabolic and functional interaction between neurons and glial cells? Brain Res Rev 14:335–353

    Article  PubMed  Google Scholar 

  95. Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW (1990) P-31 MR spectroscopy of normal human brain and brain tumors. Radiology 174:401–409

    PubMed  Google Scholar 

  96. Hugg JW, Matson GB, Twieg DB, Maudsley AA, Sappey-Marinier D, Weiner MW (1992) Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imaging 10:227–243

    Article  PubMed  Google Scholar 

  97. Hugg JW, Duijn JH, Matson GB, Maudsley AA, Tsuruda JS, Gelinas DF, Weiner MW (1992) Elevated lactate and alkalosis in chronic human brain infarction observed by H-1 and 31P MR spectroscopic imaging. J Cereb Blood Flow Metab 12:734–744

    PubMed  Google Scholar 

  98. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Husted CA, Weiner MW (1992) Lateralization of human focal epilepsy by P-31 magnetic resonance spectroscopic imaging. Neurology 42:2011–2018

    PubMed  Google Scholar 

  99. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW (1993) Neurons loss localizes focal epilepsy by proton MR spectroscopic imaging. Ann Neurol 34:788–794

    Article  PubMed  Google Scholar 

  100. Hüppi PS, Posse S, Lazeyras F, Burri R, Bossi E, Hershkowitz N (1991) Magnetic resonance in preterm and term newborns: 1H spectroscopy in developing human brain. Pediatr Res 30:574–578

    PubMed  Google Scholar 

  101. Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32:471–533

    Article  PubMed  Google Scholar 

  102. Ikeda Y, Lond DM (1990) Molecular basis of brain injury and brain edema: the role of oxygen and free radicals. Neurosurgery 27:1–11

    PubMed  Google Scholar 

  103. Isacson O (1993) On neuronal health. Trends Neurosci 16:306–308

    Article  PubMed  Google Scholar 

  104. Jenkins BG, Koroshetz WJ, Beal FM, Rosen BR (1992) Evidence for an energy metabolism defect in Huntington's disease using localized proton NMR spectroscopy. 11th Annual meeting of the Society of Magnetic Resonance in Medicine, Berlin Book of abstracts, p 755

  105. Jope RS, Jenden DJ (1979) Choline and phospholipid metabolism and the synthesis of acetylcholine in the rat brain. J Neurosci Res 4:69–82

    Article  PubMed  Google Scholar 

  106. Jingling FD, Wakhloo AK, Hennig J (1993) In vivo proton spectroscopy of meningioma after preoperative embolization. Magn Reson Med 30:155–160

    PubMed  Google Scholar 

  107. Kanashiro M, Naritomi H, Sasaki M, Tsuji S, Miyake Y (1990) Non invasive 31P NMR study on the develop ment of brain membranes of gerbils and jimpy mice, a myelin deficient mutant. Physiol Chem Phys Med NMR 22:141–154

    PubMed  Google Scholar 

  108. Kato T, Tokumaru A, O'uchi T, Mikami I, Umeda M, Nose K, Egushi T, Hasegawa M, Okuyama K (1991) Assessment of brain death in children by means of P-31 MR spectroscopy: preliminary note. Radiology 179:95–99

    PubMed  Google Scholar 

  109. Kato T, Takahashi S, Shioiri T, Inubushi T (1993) Alterations in brain phosphorus metabolism in bipolar disorder detected in vivo 31-P and 7-Li magnetic resonance spectroscopy. J Affect Disord 27:53–60

    Article  PubMed  Google Scholar 

  110. Kauppinen RA (1993) 1-H Nuclear magnetic resonance spectroscopy identifies neural cell types: a promis ing step for neuroimaging? Trends Neurosci 16:384–386

    Article  PubMed  Google Scholar 

  111. Kauppinen RA, Williams SR, Busza AL, Van Bruggen N (1993) Applications of magnetic resonance spectroscopy and diffusion-weighted imaging to the study of brain biochemistry and pathology. Trends Neurosci 16:88–95

    Article  PubMed  Google Scholar 

  112. Kauppinen RA, Niskanen T, Hakumäki J, Williams SR (1993) Quantitative analysis of 1H NMR detected proteins in the rat cerebral cortex in vivo and in vitro. NMR Biomed 6:242–247

    PubMed  Google Scholar 

  113. Kilby PM, Bolas NM, Radda GK (1991) 31P-NMR study of the brain phospholipid structures in vivo. Biochim Biophys Acta 1085:257–264

    PubMed  Google Scholar 

  114. Koller KJ, Zaczek R, Coyle JT (1984) N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effect of brain lesions as determined by a new HPLC method. J Neurochem 43:1136–1142

    PubMed  Google Scholar 

  115. Koschorek F, Gremmel H, Stelten J, Offerman W, Leibfritz D (1988) Cerebrospinal fluid: detection of tumors and disk herniations with MR spectroscopy. Neuroradiology 167:813–816

    Google Scholar 

  116. Krägeloh-Mann I, Grood W, Niemann G, Haas G, Ruitenbeck W (1992) Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol 8:60–64

    Article  PubMed  Google Scholar 

  117. Krägeloh-Mann I, Grood W, Shöning M, Marquard K, Nägele T, Ruitenbeek W (1993) Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 35:769–776

    PubMed  Google Scholar 

  118. Kreis R, Ross BD (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes melitus: detection with proton MR spectroscopy. Radiology 184:123–130

    PubMed  Google Scholar 

  119. Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27

    PubMed  Google Scholar 

  120. Kugel H, Heindel W, Ernestus R-I, Bunke J, Du Mesnil R, Friedmann G (1992) Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183:701–709

    PubMed  Google Scholar 

  121. Kuzniecky R, Elgavish GA, Hetherington HP, Evanochcko WT, Pohost GM (1992) In vivo P-31 nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy. Neurology 42:1586–1590

    PubMed  Google Scholar 

  122. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R, Cheng HM, Brady TJ, Rosen BR (1992) Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 89:5675–5679

    PubMed  Google Scholar 

  123. Larsson HBW, Christiansen P, Jensen M, Frederiksen J, Heltberg A, Olesen J, Henriksen O (1991) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 22:23–31

    PubMed  Google Scholar 

  124. Lassmann H, Zimprich F, Rossler K, Vass K (1991) Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol (Paris) 147:763–781

    Google Scholar 

  125. Lear JL (1990) Glycolysis: link between PET and proton MR spectroscopic studies of the brain. Radiology 174:328–330

    PubMed  Google Scholar 

  126. Lee JH, Ross BD (1993) Quantitation of idiogenic osmoles in human brain. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1553

  127. Levine SR, Helpern JA, Welsh KMA, Vande Linde AMQ, Sawaya KL, Brown EE, Ramadan NM, Deveshwar RK, Ordidge RJ (1992) Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology 185:537–544

    PubMed  Google Scholar 

  128. Lewis AJ (1976) Mechanisms of neurological diseases. Little Brown, Boston, pp 540

    Google Scholar 

  129. Lombes A, Bonilla E, Dimauro S (1989) Mitochondrial encephalomyopathies. Rev Neurol (Paris) 145:671–689

    Google Scholar 

  130. Marks HG, Caro PA, Wang Z, Detre JA, Bogdan AR, Gusnar DA, Zimerman RA (1991) Use of computed to mography, magnetic resonance imaging and localized 1H magnetic resonance spectroscopy in Canavan's disease. A case report. Ann Neurol 30:106–110

    Article  PubMed  Google Scholar 

  131. Martin DL (1992) Synthesis and release of neuroactive substances by glial cells. Glia 5:81–94

    Article  PubMed  Google Scholar 

  132. Martin DL, Grutter R, Boesch C (1990) In vivo NMR spectroscopy: investigation of brain in neonates and infants. Pediatrie 45:677–682

    PubMed  Google Scholar 

  133. Martin GB, Paradis NA, Helpern JA, Nowak RM, Welch KMA (1991) Nuclear magnetic resonance spectroscopy study of human brain after cardiac resuscitation. Stroke 22:462–468

    PubMed  Google Scholar 

  134. Matson GB, Weiner MW (1992) Spectroscopy. In: Shank DD, Bradley WGJr (eds) Magnetic resonance imaging, chapter 15. Mosby-Yearbook, St Louis, pp 438–478

    Google Scholar 

  135. Matson GB, Meyerhoff DJ, Lawry TJ, Lara RS, Duijn J, Deicken R, Weiner MW (1993) Use computer simulations for quantitation of P-31 ISIS MRS results. NMR Biomed 6:215–224

    PubMed  Google Scholar 

  136. Matthews PM, Andermann F, Arnold D (1990) A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 40:985–989

    PubMed  Google Scholar 

  137. Matthews PM, Francis G, Antel J, Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41:1251–1256

    PubMed  Google Scholar 

  138. Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold D (1991) In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 29:435–438

    Article  PubMed  Google Scholar 

  139. Matthews WB, Compston A, Allen IV, Martyn CN (1991) McAlpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 341–378

    Google Scholar 

  140. Maudsley AA, Hilal SK, Perman WH, Simon HE (1983) Spatially resolved high resolution spectroscopy by “four-dimensional” NMR. J Magn Res 51:147–152

    Google Scholar 

  141. Maudsley AA, Twieg DB, Sappey-Marinier D, Hubesch B, Hugg JW, Matson GB, Weiner MW (1990) Spin-echo 31P spectroscopic imaging in the human brain. Magn Reson Med 14:415–422

    PubMed  Google Scholar 

  142. McCandless DW (1985) Cerebral energy and metabolic encephalopathy. Plenum Press, New York, p 456

    Google Scholar 

  143. McComb RD, Bigner DD (1984) The biology of malignant glioma: a comprehensive survey. Clin Neuropathol 3:93–106

    PubMed  Google Scholar 

  144. McGeer PL, McGeer EG (1989) Aminoacids transmitters. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 311–332

    Google Scholar 

  145. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, Baudouin CJ, Kocsis AE, Harris JRW (1992) Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 16:538–542

    PubMed  Google Scholar 

  146. Merchant TE, Glonek T (1990) 31P NMR of phospholipids glycerol phosphodiester residues. J Lipid Res 31:479–486

    PubMed  Google Scholar 

  147. Meyerhoff DJ (1993) Magnetic resonance spectroscopic imaging. In: Gillis R (ed) NMR in physiology and medicine. Academic Press, New York (in press)

    Google Scholar 

  148. Meyerhoff DJ, MacKay S, Baker A, Schaefer S, Weiner MW (1992) Magnetic resonance spectroscopy. In: Higgins CB, Hricak H, Helm CA (eds) Magnetic resonance imaging of the body, 2nd edn. Raven Press, New York, pp 287–312

    Google Scholar 

  149. Meyerhoff DJ, MacKay RDS, Grossman N, Van Dyke C, Dillon W, Fein G, Weiner MW (1992) Effects of normal ageing and Alzheimer's disease on cerebral 1H metabolites. 11th Annual meeting of the Society of Magnetic Resonance in Medicine, Berlin. Book of abstracts, p 1931

  150. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G (1993) Reduced brain N-acetyl-aspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509–515

    PubMed  Google Scholar 

  151. Michaelis T, Merboldt KD, Hänïcke W, Gyngell ML, Bruhn H, Frahm J (1991) On the identification of cere bral metabolites in localized H-1 NMR spectra of human brain in vivo. NMR Biomed 4:90–98

    PubMed  Google Scholar 

  152. Michaelis T, Helms G, Merboldt KD, Hänïcke W, Bruhn H, Frahm J (1993) Identification of Scyllo-Inositol in proton NMR spectra of human brain in vivo. NMR Biomed 6:105–109

    PubMed  Google Scholar 

  153. Milhorat TH, Hammock MK (1983) Cerebrospinal fluid as reflection of internal milieu of brain. In: Wood JH (eds) Neurobiology of cerebrospinal fluid, Plenum Press, London, pp 1–23

    Google Scholar 

  154. Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-aspartate, creatine, and choline. NMR Biomed 4:47–52

    Google Scholar 

  155. Miller BL, Moats RA, Shonk T, Ernst T, Wooley S, Ross BD (1993) Alzheimer disease: depiction of increased myo-Inositol with proton MR spectroscopy. Radiology 187:433–437

    PubMed  Google Scholar 

  156. Minderhoud JM, Mooyaart EL, Kamman RL, Teelken AW, Hoogsraten MC, Vencken LM, Gravenmade E Jr, Van den Burg W (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49:161–165

    PubMed  Google Scholar 

  157. Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam K, Pettegrew JW (1993) A preliminary 31P study of autism. Evidence of undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33:762–773

    Article  PubMed  Google Scholar 

  158. Moonen CTW, Van Zijl PCM (1990) Highly effective water suppression for in vivo proton NMR spectroscopy (DRYSTEAM). J Magn Reson 88:28–41

    Google Scholar 

  159. Moorcraft J, Bolas NM, Ives NK, Ouwerkerk R, Smyth J, Rajagopalan B, Hope PL, Radda GK (1991) Global and depth resolved phosphorus magnetic resonance spectroscopy to predict outcome after birth asphyxia. Arch Dis Child 66:1119–1123

    PubMed  Google Scholar 

  160. Nagai Y, Naruse S, Weiner MW (1993) Effect of hypoglycemia on changes of brain lactic acid and intracellular pH produced by ischaemia. NMR Biomed 6:1–6

    PubMed  Google Scholar 

  161. Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Watari H (1984) In vivo measurement of energy metabolism and the concomitant monitoring of encephalogram in experimental ischaemia. Brain Res 296:370–372

    Article  PubMed  Google Scholar 

  162. Nicoli F, Vion-Dury J, Maloteaux JM, Delwaide C, Confort-Gouny S, Sciaky M, Cozzone PJ (1993) CSF and serum metabolic profile of patients with Huntington's chorea. A study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 154:47–51

    Article  PubMed  Google Scholar 

  163. Nielsen JB, Toft PB, Reske-Nielsen E, Jensen KE, Christiansen P, Thomsen C, Henriksen O, Lou HC (1993) Cerebral magnetic resonance spectroscopy in Rett syndrome. Failure to detect mitochondrial disorder. Brain Dev 15:107–112

    Article  PubMed  Google Scholar 

  164. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89:1671–1675

    PubMed  Google Scholar 

  165. Nordstrom CH, Rehncrona S, Siesjo BK (1990) Cerebral metabolism. In: Youmans JR (ed) Neurological surgery, 3rd edn. Saunders, Philadelphia, pp 623–651

    Google Scholar 

  166. Norris DG, Dreher W, Leibfritz D (1993) Fast 3D and 4D proton spectroscopic imagingusing the sliced-k-space method. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 896

  167. Ohnishi T, Posner JB, Shapiro WR (1992) Vasogenic brain edema induced by arachidonic acid: role of extracellular arachidonic acid in bloodbrain barrier dysfunction. Neurosurg 30:545–551

    Google Scholar 

  168. Peden CJ, Cowan FM, Bryant DJ, Sargentoni J, Cox IJ, Menon DK, Gadian DG, Bell JD, Dubowitz LM (1990) Proton MR spectroscopy of the brain in infant. J Comput Assist Tomogr 14:886–894

    PubMed  Google Scholar 

  169. Peden CJ, Rutherford MA, Sargentoni J, Cox IJ, Bryant DJ, Dubowitz LM (1993) Proton spectroscopy of the neonatal brain following hypoxicischaemic injury. Dev Med Child Neurol 35:502–510

    PubMed  Google Scholar 

  170. Perry TL, Hansen S, Beery K, Mok C, Lesk D (1971) Free aminoacids and related compounds in biopsies of the human brain. J Neurochem 18:521–528

    PubMed  Google Scholar 

  171. Petroff OAC, Pritchard JW, Behar KL, Alger JR, Den Hollander JA, Shulman RG (1985) Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 35:781–788

    PubMed  Google Scholar 

  172. Petroff OAC, Yu RK, Ogino T (1986) High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J Neurochem 47:1270–1276

    PubMed  Google Scholar 

  173. Petroff OAC, Graham GD, Blamire AM, Al Rayess M, Rothman DL, Fayad PB, Brass LM, Shulman RG, Prichard JW (1992) Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42:1349–1354

    PubMed  Google Scholar 

  174. Pettegrew JW, Withers G, Panchalingam K, Post JFM (1987) 31P nuclear magnetic resonance (NMR) spectroscopy of brain in ageing and Alzheimer's disease. Neural Transm [Suppl] 24:261–268

    Google Scholar 

  175. Plaitakis A (1990) Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: an hypothesis. Ann Neurol 28:3–7

    Article  PubMed  Google Scholar 

  176. Preece NE, Williams SR, Jackson G, Duncan JS, Houseman J, Gadian DG (1991) 1-H NMR studies of viga-batrin induced increase in cerebral GABA. 10th Congress of Magnetic Resonance in Medicine, San Francisco, USA. Book of Abstracts, p 1000

  177. Preece NE, Baker D, Butter C, Gadian DG, Urenjak J (1993) Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 13 guinea-pigs. NMR Biomed 6:194–200

    PubMed  Google Scholar 

  178. Prichard JW (1992) Magnetic resonance spectroscopy of the brain. Clin Chim Acta 206:115–123

    Article  PubMed  Google Scholar 

  179. Prichard JW (1992) The ischaemic penumbra in stroke: prospects for analysis by nuclear magnetic resonance spectroscopy. In: Waxman SG (ed) Molecular and cellular approaches to the treatment of neurological disease. Raven Press, New York, pp 153–174

    Google Scholar 

  180. Pulsinelli WA, Cooper AJL (1989) Metabolic encephalopathies and coma. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 765–781

    Google Scholar 

  181. Quarles RH, Morell P, McFarlin DE (1989) Diseases involving myelin. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 697–713

    Google Scholar 

  182. Richards TL (1991) Proton NMR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression and evaluating therapy. Am J Roentgenol 157:1073–1078

    Google Scholar 

  183. Ross BD (1991) Biochemical considerations in 114 spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 4:59–63

    PubMed  Google Scholar 

  184. Roth K, Hubesch B, Meyerhoff DJ, Naruse E, Gober S, Lawry TJ, Boska MD, Matson GB, Weiner MW (1989) Non invasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy. J Magn Res 81:299–311

    Google Scholar 

  185. Rothman DL, Hanstock CC, Petroff OAC, Novotny EJ, Prichard JW, Schulman RG (1992) Localized 1H NMR spectra of glutamate in the human brain. Magn Reson Med 25:94–106

    PubMed  Google Scholar 

  186. Rothman DL, Petroff OAC, Behar KL, Matson RH (1993) Localized 1-H NMR measurement of γ-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 90:5662–5666

    PubMed  Google Scholar 

  187. Ruiz-Cabello J, Cohen JS (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226–233

    PubMed  Google Scholar 

  188. Salford LG, Plum F, Siesjö BK (1973) Graded hypoxia-oligemia in rat brain. I. Biochemical alterations and their implications. Arch Neurol 29:227–233

    PubMed  Google Scholar 

  189. Salford LG, Plum F, Brierley JB (1973) Graded hypoxia-oligemiain rat brain. II. Neuropathological alter ations and their implications. Arch Neurol 29:234–238

    PubMed  Google Scholar 

  190. Sappey-Marinier D, Hubesch B, Matson GB, Weiner MW (1992) Decreased phosphorus metabolite concentration and alkalosis in chronic cerebral infarction. Radiology 182:29–34

    PubMed  Google Scholar 

  191. Sappey-Marinier D, Deicken RE, Fein G, Calabrese G, Hubesch B, Van Dyke C, Dillon W, Davenport L, Meyerhoff DJ, Weiner MW (1992) Alterations in brain phosphorus metabolite concentration associated with areas of high signal intensity in white matter at MR imaging. Radiology 183:247–256

    PubMed  Google Scholar 

  192. Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SNG, Deicken RE, Van Dyke C, Fein G, Weiner MW (1992) Proton magnetic resonance spectroscopy of the human brain: application to the normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 26:313–327

    PubMed  Google Scholar 

  193. Scheinberg P (1991) The biologic basis for the treatment of acute stroke. Neurology 41:1867–1873

    PubMed  Google Scholar 

  194. Shulman RG, Blamire AM, Rothman DL, McCarthy G (1993) Nuclear magnetic resonance imaging and spectroscopy of the brain function. Proc Natl Acad Sci USA 90:3127–3133

    PubMed  Google Scholar 

  195. Siesjo BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155–185

    PubMed  Google Scholar 

  196. Siesjo BK (1990) Calcium, excitotoxins and brain damage. Physiol Sci 5:120–125

    Google Scholar 

  197. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37–45

    Article  PubMed  Google Scholar 

  198. Skolnick AA (1993) Magnetic resonance spectroscopy may offer early look at HIV disease-mediated changes in brain. JAMA 269:1084

    Article  PubMed  Google Scholar 

  199. Smith CD, Gallenstein LG, Layton WJ, Kryscios RJ, Markesvery WR (1993) 31-P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol Ageing 14:85–92

    Article  Google Scholar 

  200. Sutton LN, Wang Z, Gusnard D, Lange B, Periolongo G, Bogdan AR, Detre JA, Rorke L, Zimmerman RA (1992) Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195–202

    PubMed  Google Scholar 

  201. Tanaka C, Naruse S, Horikawa Y, Higushi T, Hirakawa K, Nishikawa H (1985) Investigation of pathophysiology in ischemic brain edema with 1H-NMR and 31P-NMR. In: Inaba Y (ed) Brain edema. Springer, Berlin Heidelberg New York, pp 465–473

    Google Scholar 

  202. Toole JF (1990) Cerebrovascular disorders. Raven Press, New York

    Google Scholar 

  203. Twieg DB, Meyerhoff DJ, Roth K, Sappey-Marinier D, Boska MD, Gober JR, Schaefer S, Weiner MW (1989) Phosphorus-31 magnetic resonance spectroscopy in human by spectroscopic imaging: localized spectroscopy and metabolite imaging. Magn Reson Med 12:291–305

    PubMed  Google Scholar 

  204. Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55–61

    PubMed  Google Scholar 

  205. Van der Knaap MS, Van der Grond J, Van Rijen PC, Faber JAJ, Valk J, Willeme K (1990) Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176:509–515

    PubMed  Google Scholar 

  206. Van der Knaap MS, Van der Grond J, Luyten PR, Hollander JA den, Nauta JJP, Valk J (1992) 1H and 31P magnetic resonance spectroscopy of brain degenerative cerebral disorders. Ann Neurol 31:202–211

    Article  PubMed  Google Scholar 

  207. Van Hecke P, Marchal G, Johannick K, Demaerel P, Wilms G, Carton H, Baert AL (1991) Human brain proton localized spectroscopy in multiple sclerosis. Magn Reson Med 18:199–206

    PubMed  Google Scholar 

  208. Van Zijl PCM, Moonen CTW (1992) Solvent suppression strategies for in vivo magnetic resonance spectroscopy. In: Diehl P, Fluck E, Gunther H, Kosfeld R, Seelig J (eds) NMR, basic principles and progress. Springer, Berlin Heidelberg New York, pp 67–108

    Google Scholar 

  209. Vion-Dury J, Nicoli F, Torri G, Torri J, Kriat M, Sciaky M, Davin A, Viout P, Confort-Gouny S, Cozzone PJ (1992) High resolution NMR spectroscopy of physiological fluids: from metabolism to physiology. Biochimie 74:801–807

    Article  PubMed  Google Scholar 

  210. Vion-Dury J, Confort-Gouny S, Nicoli F, Dhiver C, Gastaut JA, Gastaut Cozzone PJ (1993) Localized brain proton MRS in neurologic complications of AIDS: value for diagnosis and prognosis. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1563

  211. Waltz W (1989) Role of glial cells in the regulation of the brain ion microenvironment. Prog Neurobiol 33:309–333

    Article  PubMed  Google Scholar 

  212. Weiner MW, Hetherington HP (1989) The power of the proton. Radiology 172:318–320

    PubMed  Google Scholar 

  213. Welch KA, Levine SR, D'Andrea G, Helpern JA (1988) Brain pH in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalagia 8:23–27

    Article  Google Scholar 

  214. Welch KA, Levine SR, D'Andrea G, Schultz LR, Helpern JA (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus-31 NMR spectroscopy. Neurology 39:538–541

    PubMed  Google Scholar 

  215. Welch KMA, Levine SR, Martin G, Ordidge R, Van de Linde AQ, Helpern JA (1992) Magnetic reso nance spectroscopy in cerebral ischaemia. In: Cerebral ischaemia: treatment and prevention. Neurol Clin 10:1–29

    Google Scholar 

  216. Youngner SJ (1992) Defining death. A superficial and fragile consensus. Arch Neurol 49:570–572

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Résonance Magnétique Biologique et Médicale, URA CNRS 1186, Faculté de Médecine, Bd J. Moulin, F-13005, Marseille, France

    J. Vion-Dury & P. J. Cozzone

  2. Department of Veterans Affairs Medical Center, 4150 Clement Street, USA

    D. J. Meyerhoff & M. W. Weiner

  3. Departments of Radiology and Medicine, University of California, 94121, San Francisco, CA, USA

    D. J. Meyerhoff & M. W. Weiner

Authors
  1. J. Vion-Dury
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. J. Meyerhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. J. Cozzone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. W. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vion-Dury, J., Meyerhoff, D.J., Cozzone, P.J. et al. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 241, 354–371 (1994). https://doi.org/10.1007/BF02033352

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02033352

Key words

Search

Navigation